NEW YORK (GenomeWeb News) – Rules-Based Medicine, an Austin, Texas-based multiplex molecular diagnostics firm, has filed a registration statement with the US Securities and Exchange Commission for an initial public offering of common stock.

RBM did not disclose in the preliminary prospectus how many shares it intends to offer, an estimated price range for the offering, or an estimate for the proceeds it hopes to raise through the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.